Suppression of Vascular Endothelial Growth Factor-Mediated Endothelial Cell Protection by Survivin Targeting
- 1 May 2001
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 158 (5), 1757-1765
- https://doi.org/10.1016/s0002-9440(10)64131-4
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HL54131, HL61371, CA78810, HL10112, HL64793, HL51014)
This publication has 40 references indexed in Scilit:
- Angiopoietin-1 Inhibits Endothelial Cell Apoptosis via the Akt/Survivin PathwayJournal of Biological Chemistry, 2000
- Control of Apoptosis during Angiogenesis by Survivin Expression in Endothelial CellsThe American Journal of Pathology, 2000
- Expression and Targeting of the Apoptosis Inhibitor, Survivin, in Human MelanomaJournal of Investigative Dermatology, 1999
- Marked Induction of the IAP Family Antiapoptotic Proteins Survivin and XIAP by VEGF in Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 1999
- Vascular Endothelial Growth Factor (VEGF)-Mediated Angiogenesis Is Associated with Enhanced Endothelial Cell Survival and Induction of Bcl-2 ExpressionThe American Journal of Pathology, 1999
- Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction PathwayJournal of Biological Chemistry, 1998
- The Bcl-2 Protein Family: Arbiters of Cell SurvivalScience, 1998
- Nuclear Factor (NF)-κB–regulated X-chromosome–linked iap Gene Expression Protects Endothelial Cells from Tumor Necrosis Factor α–induced ApoptosisThe Journal of Experimental Medicine, 1998
- Mechanisms of angiogenesisNature, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996